Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Neoplasms × Temozolomide × Clear all

Sponsor

Conditions

Glioblastoma 104 Brain Neoplasms 50 Gliosarcoma 48 Glioma 42 Central Nervous System Neoplasms 28 Astrocytoma 27 Melanoma 21 Oligodendroglioma 14 Neuroblastoma 10 Neoplasm Metastasis 8 Ependymoma 7 Recurrence 6 Neoplasms 6 Sarcoma, Ewing 5 Lymphoma 5 Spinal Cord Neoplasms 4 Skin Neoplasms 4 Sarcoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Medulloblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Somatostatinoma 3 Gastrinoma 3 Colorectal Neoplasms 3 Carcinoma, Islet Cell 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Pinealoma 2 Pancreatic Neoplasms 2

Interventions

pembrolizumab 4 Gemcitabine 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 Bupropion 2 tocilizumab 1 tislelizumab 1 spartalizumab 1 infigratinib 1 etoposide phosphate 1 cc-486 1 avelumab 1 Zoledronic Acid 1 Vorinostat 1 Tobacco Use Cessation Devices 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Pilocarpine 1 Oral Hygiene 1 Ifosfamide 1 Gene Expression Profiling 1 Fluorouracil 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Etoposide 1 Early Intervention, Educational 1 Dexamethasone 1 Counseling 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡